Related Experiment Videos
[Three years experience of using mycosyst]
Akusherstvo I Ginekologiia
|November 3, 2004
Summary
Mycosyst (Fluconazole) effectively treats mycotic colpitis in women, with symptoms resolving within 4 days. A single or two-dose regimen of 150 mg is sufficient for most acute cases.
Area of Science:
- Medical Mycology
- Pharmacology
Context:
- Mycotic colpitis, commonly known as vaginal candidiasis, affects women of various ages.
- Diagnosis and treatment of vaginal candidiasis are crucial for women's reproductive health.
Purpose:
- To evaluate the therapeutic efficacy of Mycosyst (Fluconazole) in treating mycotic colpitis.
- To assess the pharmacokinetics and optimal dosage of Mycosyst for vaginal candidiasis.
Summary:
- A study involving 157 women investigated Mycosyst (Fluconazole) for mycotic colpitis.
- Patients experienced symptom relief within 48 hours, with significant improvement by day 4.
- A two-dose regimen of 150 mg Mycosyst achieved a success rate of approximately 95% in acute cases.
Impact:
- Mycosyst demonstrates rapid symptom relief and high efficacy for vaginal candidiasis.
- Its favorable pharmacokinetic profile allows for single or two-dose treatment regimens.
- The cost-effectiveness of Mycosyst makes it an accessible treatment option.